Baicalein selectively induce apoptosis in human leukemia K562 cells / 药学学报
Acta Pharmaceutica Sinica
;
(12): 817-820, 2003.
Article
in Chinese
| WPRIM
| ID: wpr-266577
ABSTRACT
<p><b>AIM</b>To study the antitumor effect of baicalein on human leukemia K562 cell and its mechanism.</p><p><b>METHODS</b>The IC50 value and cytotoxity of K562 cell were detected by MTT method. The apoptotic cell was analyzed by FCM using Annexin V FITC--PI staining method. Sub-G1 peak was also measured by FCM. Protein expressions of Bcl-2, Fas, Caspase 3 were evaluated with FCM.</p><p><b>RESULTS</b>Baicalein was shown to significantly inhibit the proliferation of K562 cell in a dose-dependent manner and selectively induce apoptosis of human leukemia K562 cells. Flow cytometric analysis showed that baicalein arrested K562 cells in the S phase. In addition, protein expression of Fas, Caspase 3 of K562 cells increased after exposure to baicalein, but Bcl-2 was unchanged.</p><p><b>CONCLUSION</b>Baicalein can selectively induce apoptosis of human leukemia K562 cell dose and time dependently through up-regulation of caspase-3 and fas gene expression level.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pharmacology
/
Flavonoids
/
Cell Cycle
/
Up-Regulation
/
Apoptosis
/
Proto-Oncogene Proteins c-bcl-2
/
K562 Cells
/
Caspases
/
Flavanones
/
Caspase 3
Limits:
Humans
Language:
Chinese
Journal:
Acta Pharmaceutica Sinica
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS